StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3081% below fair value
$0.88−0.21 (-19.25%)

Close on Nov 16, 2026Market cap $4.21MP/E –Yield –

Sonoma Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Sonoma Pharmaceuticals

Sonoma Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Sonoma Pharmaceuticals figures

See a number that looks wrong?